I wanted to make a point of placing the monsters within the daily life of Tokyo,” says the photographer Tess Ayano, who spent ...

Myanmar’s military leader says 144 people ... A 49ft wave crashed into the Fukushima Daiichi nuclear plant, more than 30 miles inland, knocking out the cooling systems of three of the reactors.

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

As the second antibody-drug conjugate launched by Daiichi Sankyo and AstraZeneca, Datroway has a tough act to follow, coming on the heels of the companies’ emerging ADC cancer powerhouse Enhertu.

At the annual National Cherry Blossom Festival this year, which wrapped up this past weekend, Japanese drugmaker Daiichi Sankyo went back to visit the roots it planted in the nation’s capital ...

Daiichi Sankyo reported full-year revenue of JPY 1,886 billion and core operating profit of JPY 332 billion. It issued full-year guidance of JPY 2 trillion revenue and JPY 350 billion core ...

Dan Switzer, head of the US oncology business division at Daiichi Sankyo, spoke with Pharmaceutical Executive about the company’s history with this festival and it connects to its current values.

A cancer drug from partners AstraZeneca and Daiichi Sankyo currently approved as a second-line or later treatment for metastatic breast cancer has interim clinical data showing it helped patients ...

TOKYO -- Dai-ichi Life Holdings will acquire a 15% stake in Australian insurer Challenger, Nikkei has learned, the latest move by a Japanese insurance company in Australia. Dai-ichi will buy all ...